Journal profile · PSYCHIATRY

Translational Psychiatry

ISSN 2158-3188 · Springer Nature · UNITED STATES · Founded 2011

Translational Psychiatry: CAS Zone 2 · Medicine (2025 upgraded edition, Top journal); impact factor 7.48; fully open access; APC about USD 5,490; median 257 days to acceptance (150 articles, last 24 months); 575 articles in 2025; indexed in SCIE and Scopus.

Impact factor7.48Latest value listed by LetPub
CAS zoneZone 2 · Medicine2025 upgraded edition, major category · Top journal · 2026 Xinrui edition Zone 1 · Medicine
Review time257 daysMedian, submission to acceptance · 150 articles, last 24 months · Crossref
APCUSD 5,490Fully open access
Acceptance—No reports yet
Articles per year5752025 · OpenAlex count

Scope

Aims, scope and focus

Translational Psychiatry is published by Springer Nature and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Tryptophan and brain disorders, Functional Brain Connectivity Studies and Stress Responses and Cortisol, together about 27.8% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Bridges the gap between advances in neuroscience and conceptually novel treatments. Expands visibility for both mechanistic and clinical research through open access. Supported by a highly respected global Editorial Board.

From the journal's Aims & Scope

Research area (LetPub): PSYCHIATRY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Tryptophan and brain disordersNeuroscience11%
  2. Functional Brain Connectivity StudiesNeuroscience9%
  3. Stress Responses and CortisolNeuroscience7.8%
  4. Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology5.5%
  5. Genetic Associations and EpidemiologyBiochemistry, Genetics and Molecular Biology5%
  6. Autism Spectrum Disorder ResearchNeuroscience5%
  7. Neurotransmitter Receptor Influence on BehaviorNeuroscience4.9%
  8. Neuroscience and Neuropharmacology ResearchNeuroscience4.5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorPsychiatryZone 2

Top journal: yesReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorPsychiatryZone 1

Top journal: yesReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
LevelCategoryZone
MajorMedicineZone 1
MinorPsychiatryZone 1

Top journal: yesReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

Web of ScienceMEDLINEPMCPublisher website

Other: Crossref

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
7.48LetPub ·
Impact factor (publisher) 2025
7.5Publisher website ·
5-year impact factor (publisher) 2025
7.8Publisher website ·
CiteScore 2026-06
10.7LetPub ·
SJR 2026-06
2.42LetPub ·
SNIP 2026-06
1.81LetPub ·
h-index
65LetPub ·
h-index
184OpenAlex ·
i10-index
3,916OpenAlex ·
2-year mean citedness
6.39OpenAlex ·
Self-citation rate
2.7%LetPub ·
Share of gold OA articles
99.86%LetPub ·

Volume

Articles per year
565LetPub ·
Downloads per year (publisher) 2025
12,496,187Publisher website ·

Articles by year OpenAlex count · 5,691 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026676676359
20255755753,353
20245085087,534
202340440411,226
202253053016,448
202164764728,397

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

257 daysMedian, submission to acceptance · P25–P75 183 days – 340 days

Acceptance to online
median 15 days (150 articles)
Submission to online
median 276 days
Sample
150 articles with submission and acceptance dates (1,349 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 23 weeksLetPub ·
Submission to publication (journal-reported)
about 23 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 4,190 / USD 5,490 / GBP 3,590YesCC BY, CC BY-NC-ND
OpenAlexUSD 5,290 / EUR 3,990 / GBP 3,490——
LetPubGBP 3,290 / USD 4,990 / EUR 3,690Yes—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Policy excerpts from the journal's websitePublication ethics
Publication ethics

COPE member Model summary

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Springer Nature
Country or region
UNITED STATES
Language
English
Founded
2011
ISSN
2158-3188
Official links

FAQ

Frequently asked questions about Translational Psychiatry

What CAS zone is Translational Psychiatry in?

In the 2025 upgraded edition of the CAS Journal Ranking, Translational Psychiatry is in Zone 2 of Medicine, and in Zone 2 of the minor category Psychiatry; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Translational Psychiatry?

The latest impact factor listed by LetPub is 7.48; CiteScore 10.7, h-index 184.

How long does peer review take at Translational Psychiatry?

Based on the dates recorded on 150 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 257 days (interquartile range 183–340 days); authors report an average review time of about 23 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Translational Psychiatry?

According to LetPub and DOAJ records, Translational Psychiatry is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE and PMC; that list has not been checked against each database.

Is Translational Psychiatry open access, and what is the APC?

Translational Psychiatry is a fully open-access journal. APC about USD 5,490.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .